• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由囊性纤维化患者和医疗保健提供者组成的合作伙伴关系制定的囊性纤维化十大研究重点。

The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers.

机构信息

Evidence Based Child Health Group, University of Nottingham, Nottingham, UK.

School of Medicine, NIHR Research Design Service for the East Midlands, University of Nottingham, Nottingham, UK.

出版信息

Thorax. 2018 Apr;73(4):388-390. doi: 10.1136/thoraxjnl-2017-210473. Epub 2017 Aug 4.

DOI:10.1136/thoraxjnl-2017-210473
PMID:28778919
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5870449/
Abstract

There remain many treatment uncertainties in cystic fibrosis (CF). With limited resources, research should focus on questions which are most important to the CF community. We conducted a James Lind Alliance Priority Setting Partnership in CF. Research questions were elicited and then prioritised in successive surveys. A workshop agreed the final top 10. Online methods avoided cross infection and widened participation. The elicitation survey had 482 respondents (1080 questions) and prioritisation survey 677 respondents. Participants were drawn equally from the patient and clinical communities globally. We have achieved a consensus on 10 research priorities which will be attractive to funders.

摘要

囊性纤维化 (CF) 的治疗仍存在许多不确定性。由于资源有限,研究应集中在对 CF 社区最重要的问题上。我们在 CF 中进行了一项詹姆斯林德联盟优先事项设定伙伴关系。通过连续的调查来引出和优先考虑研究问题。一个研讨会确定了最终的前 10 名。在线方法避免了交叉感染,扩大了参与度。征求意见调查有 482 名受访者(1080 个问题),而优先排序调查有 677 名受访者。参与者来自全球的患者和临床社区。我们已经就 10 项研究重点达成共识,这些重点将对资助者具有吸引力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbd6/5870449/a15cee9782b4/thoraxjnl-2017-210473f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbd6/5870449/a15cee9782b4/thoraxjnl-2017-210473f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbd6/5870449/a15cee9782b4/thoraxjnl-2017-210473f01.jpg

相似文献

1
The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers.由囊性纤维化患者和医疗保健提供者组成的合作伙伴关系制定的囊性纤维化十大研究重点。
Thorax. 2018 Apr;73(4):388-390. doi: 10.1136/thoraxjnl-2017-210473. Epub 2017 Aug 4.
2
Adapting the James Lind Alliance priority setting process to better support patient participation: an example from cystic fibrosis.调整詹姆斯·林德联盟的优先事项设定流程以更好地支持患者参与:来自囊性纤维化的一个例子。
Res Involv Engagem. 2019 Aug 20;5:24. doi: 10.1186/s40900-019-0159-x. eCollection 2019.
3
Identifying and prioritising unanswered research questions for people with hyperacusis: James Lind Alliance Hyperacusis Priority Setting Partnership.确定和优先考虑患有听觉过敏症人群的未解决研究问题:詹姆斯林德联盟听觉过敏优先事项设定伙伴关系。
BMJ Open. 2019 Nov 21;9(11):e032178. doi: 10.1136/bmjopen-2019-032178.
4
Identifying research priorities in breast cancer surgery: a UK priority setting partnership with the James Lind Alliance.确定乳腺癌手术研究重点:英国与詹姆斯林德联盟的优先事项设定伙伴关系。
Breast Cancer Res Treat. 2023 Jan;197(1):39-49. doi: 10.1007/s10549-022-06756-4. Epub 2022 Nov 1.
5
Research priorities for the management of broken bones of the upper limb in people over 50: a UK priority setting partnership with the James Lind Alliance.50 岁以上人群上肢骨折管理的研究重点:英国与詹姆斯林德联盟的优先事项设定伙伴关系。
BMJ Open. 2019 Dec 15;9(12):e030028. doi: 10.1136/bmjopen-2019-030028.
6
Research priorities for the management of major trauma: an international priority setting partnership with the James Lind Alliance.重大创伤管理的研究重点:与詹姆斯·林德联盟的国际优先事项设定伙伴关系。
BMJ Open. 2024 May 15;14(5):e083450. doi: 10.1136/bmjopen-2023-083450.
7
Research priorities for the management of complex fractures: a UK priority setting partnership with the James Lind Alliance.复杂骨折管理的研究重点:英国与詹姆斯·林德联盟的优先事项设定伙伴关系。
BMJ Open. 2021 Nov 30;11(11):e057198. doi: 10.1136/bmjopen-2021-057198.
8
Top research priorities for preterm birth: results of a prioritisation partnership between people affected by preterm birth and healthcare professionals.早产重点研究议题:受早产影响的人群与医疗保健专业人员之间的优先伙伴关系的结果。
BMC Pregnancy Childbirth. 2019 Dec 30;19(1):528. doi: 10.1186/s12884-019-2654-3.
9
Priorities for research in miscarriage: a priority setting partnership between people affected by miscarriage and professionals following the James Lind Alliance methodology.流产研究的优先事项:流产患者与专业人员依据詹姆斯·林德联盟方法开展的优先事项设定合作项目
BMJ Open. 2017 Aug 23;7(8):e016571. doi: 10.1136/bmjopen-2017-016571.
10
Identifying primary care patient safety research priorities in the UK: a James Lind Alliance Priority Setting Partnership.确定英国初级保健患者安全研究重点:詹姆斯·林德联盟优先事项设定合作项目
BMJ Open. 2018 Feb 28;8(2):e020870. doi: 10.1136/bmjopen-2017-020870.

引用本文的文献

1
Identifying research priorities for pregnant South Asian immigrants in Canada: A James Lind Alliance approach.确定加拿大南亚裔孕妇的研究重点:詹姆斯·林德联盟方法。
PLoS One. 2025 Aug 28;20(8):e0330628. doi: 10.1371/journal.pone.0330628. eCollection 2025.
2
Pancreatic, nutritional and clinical outcomes in children 0-5 years with cystic fibrosis during the first 2 years of CFTR modulator therapy (PaNC): a multicentre prospective observational study protocol.囊性纤维化跨膜传导调节因子调节剂治疗(PaNC)前两年0至5岁囊性纤维化儿童的胰腺、营养和临床结局:一项多中心前瞻性观察研究方案
BMJ Open. 2025 Jul 30;15(7):e097071. doi: 10.1136/bmjopen-2024-097071.
3

本文引用的文献

1
Gaps in the evidence for treatment decisions in cystic fibrosis: a systematic review.囊性纤维化治疗决策证据中的差距:系统评价。
Thorax. 2019 Mar;74(3):229-236. doi: 10.1136/thoraxjnl-2017-210858. Epub 2018 Oct 9.
2
The patient voice in research - Supporting actor or starring role?研究中的患者声音——配角还是主角?
J Cyst Fibros. 2017 May;16(3):313-314. doi: 10.1016/j.jcf.2017.03.001. Epub 2017 Mar 9.
3
Perception of first respiratory infection with Pseudomonas aeruginosa by people with cystic fibrosis and those close to them: an online qualitative study.
Real-world improvement in ultra-low-dose thoracic computed tomography scores, systemic inflammatory markers and patient-reported outcome measures after elexacaftor/tezacaftor/ivacaftor treatment.
依列卡福妥/替扎卡福妥/依伐卡托治疗后,超低剂量胸部计算机断层扫描评分、全身炎症标志物及患者报告结局指标的真实世界改善情况。
ERJ Open Res. 2025 Jun 2;11(3). doi: 10.1183/23120541.00897-2024. eCollection 2025 May.
4
A Qualitative Study to Improve How We Partner With Patients and Families in Healthcare Improvement Collaboratives.一项关于改善我们在医疗保健改进合作中与患者及家属合作方式的定性研究。
Health Expect. 2025 Jun;28(3):e70312. doi: 10.1111/hex.70312.
5
Reducing Treatment Burden in Cystic Fibrosis: Is There a Risk to OverSIMPLIFYing Therapies?减轻囊性纤维化的治疗负担:过度简化治疗方法是否存在风险?
Ann Am Thorac Soc. 2024 Nov;21(11):1483-1484. doi: 10.1513/AnnalsATS.202407-694ED.
6
Collaboration between registered dietitians and gastroenterologists in cystic fibrosis care: Results of an international cross-sectional survey.注册营养师与胃肠病学家在囊性纤维化护理中的合作:一项国际横断面调查结果
Nutr Clin Pract. 2025 Feb;40(1):195-208. doi: 10.1002/ncp.11219. Epub 2024 Oct 8.
7
A randomised crossover trial of tezacaftor-ivacaftor for gut dysfunction in cystic fibrosis with magnetic resonance imaging (MRI) outcomes: a pilot study.一项关于tezacaftor-ivacaftor治疗囊性纤维化肠道功能障碍并以磁共振成像(MRI)结果为指标的随机交叉试验:一项试点研究。
NIHR Open Res. 2024 Mar 19;3:65. doi: 10.3310/nihropenres.13510.2. eCollection 2023.
8
Presentation, characteristics and management of obstructive intestinal conditions in cystic fibrosis.囊性纤维化中梗阻性肠道疾病的表现、特征及管理
Frontline Gastroenterol. 2024 Jan 6;15(3):222-227. doi: 10.1136/flgastro-2023-102533. eCollection 2024 May.
9
Perceived burden of respiratory physiotherapy in people with cystic fibrosis taking elexacaftor-tezacaftor-ivacaftor combination: a 1-year observational study.囊性纤维化患者使用依利卓艾卡托替卡那三联组合治疗的呼吸物理治疗感知负担:一项为期 1 年的观察性研究。
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241235054. doi: 10.1177/17534666241235054.
10
Scoring Abdominal Symptoms in People with Cystic Fibrosis.对囊性纤维化患者的腹部症状进行评分
J Clin Med. 2024 Mar 13;13(6):1650. doi: 10.3390/jcm13061650.
囊性纤维化患者及其身边的人对首次感染铜绿假单胞菌引起的呼吸道感染的认知:一项在线定性研究。
BMJ Open. 2016 Dec 28;6(12):e012303. doi: 10.1136/bmjopen-2016-012303.
4
Advancing clinical development pathways for new CFTR modulators in cystic fibrosis.推进囊性纤维化新型CFTR调节剂的临床开发路径。
Thorax. 2016 May;71(5):454-61. doi: 10.1136/thoraxjnl-2015-208123. Epub 2016 Feb 22.
5
Infection prevention and control guideline for cystic fibrosis: 2013 update.囊性纤维化感染预防与控制指南:2013年更新版
Infect Control Hosp Epidemiol. 2014 Aug;35 Suppl 1:S1-S67. doi: 10.1086/676882. Epub 2014 Jul 1.
6
Finding and filling the gaps in the evidence with high quality clinical trials - the experience of one Cochrane Review Group.通过高质量临床试验发现和填补证据空白——一个 Cochrane 综述组的经验。
J Evid Based Med. 2013 Nov;6(4):229-31. doi: 10.1111/jebm.12073.
7
Schizophrenia: Patients' research priorities get funded.精神分裂症:患者的研究重点获得资助。
Nature. 2012 Jul 25;487(7408):432. doi: 10.1038/487432b.
8
Consensus development methods, and their use in clinical guideline development.共识发展方法及其在临床指南制定中的应用。
Health Technol Assess. 1998;2(3):i-iv, 1-88.